The Clorox Company (NYSE:CLX) Given Average Recommendation of “Reduce” by Brokerages

Shares of The Clorox Company (NYSE:CLX) have been given a consensus recommendation of “Reduce” by the eighteen analysts that are presently covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and one has issued a buy rating on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $125.6875.

CLX has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft cut their price target on Clorox from $128.00 to $121.00 and set a “hold” rating on the stock in a report on Tuesday, November 4th. Morgan Stanley lowered their target price on Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 4th. BNP Paribas Exane reduced their price target on shares of Clorox from $110.00 to $103.00 and set an “underperform” rating for the company in a research report on Tuesday, November 4th. Wells Fargo & Company decreased their price target on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Center for Financial Planning Inc. purchased a new stake in Clorox in the 3rd quarter valued at $25,000. Total Investment Management Inc. bought a new stake in shares of Clorox in the 2nd quarter worth $25,000. American National Bank & Trust grew its stake in shares of Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after acquiring an additional 89 shares in the last quarter. True Wealth Design LLC raised its holdings in shares of Clorox by 1,020.0% in the third quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after purchasing an additional 204 shares during the last quarter. Finally, NewSquare Capital LLC lifted its position in shares of Clorox by 567.6% during the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after purchasing an additional 193 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 4.0%

CLX opened at $104.09 on Friday. The company has a fifty day moving average price of $115.29 and a two-hundred day moving average price of $122.29. Clorox has a 1-year low of $98.20 and a 1-year high of $171.37. The company has a market cap of $12.70 billion, a P/E ratio of 15.96, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same quarter in the prior year, the firm earned $1.86 EPS. The business’s revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Analysts predict that Clorox will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be given a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 annualized dividend and a yield of 4.8%. Clorox’s dividend payout ratio (DPR) is presently 77.86%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.